Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of March 2025, with a specific reporting date of March 14, 2025. The document serves as a notification of a transaction by a Person Closely Associated (PCA) with a Person Discharging Managerial Responsibilities (PDMR) under Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to a specific share transaction:
- Transaction Type: Purchase of American Depositary Shares (ADS).
- Volume: 1,750 ADS.
- Price per ADS: USD $20.9539.
- Total Transaction Value: USD $36,669.33.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses an insider-related share purchase transaction.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory disclosure of a specific transaction executed on the New York Stock Exchange on March 12, 2025.
Key Facts for Investor Verification
- The transaction was executed by the Trustees of the David John Frear Revocable Trust, a PCA of David Frear, a Non-Executive Director.
- Each ADS represents five ordinary shares of one pence each in the capital of the Company.
- The transaction was a purchase, indicating an increase in holdings by the associated party.
- The filing does not contain quarterly or annual financial results; investors should refer to Form 20-F for comprehensive financial data.